KeifeRx
Business Services · Virginia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1356 Beverly Rd Ste 300, Mc Lean, Virgin...Website
www.keiferx.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About KeifeRx
Headquartered in Mclean, VA, KeifeRx is a biotechnology company with a focus on neurodegenerative diseases.Explore more
KeifeRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KeifeRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
KeifeRx, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on KeifeRx recently announced quarterly report
Product Launch: Get notified when KeifeRx launches new products
Website visits: Recent activity has been detected on your website
Click to see if KeifeRx had a recent Job posting/layoffs
Funding: Get notified immidiatlly once KeifeRx has new funding data
Check out if KeifeRx is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at KeifeRx
Check if KeifeRx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at KeifeRx
Find 2 more new buyers
Compare Similar Companies to KeifeRx
Compare insights from companies similar to KeifeRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
<$5M
2005
CL
Cynthia LevinthalPrincipal Consultant. Neural Stem Cell Therapies. Clinical Trials
Company Profile Activity
Activity Insights
KeifeRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KeifeRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KeifeRx.
KeifeRx financials insights
Gather financial insights about KeifeRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$6M
KeifeRx Tech Stack
A closer look at the technologies used by KeifeRx
See more technologies
Most Recent Scoops
Executive Move
Board of Directors
Executive Move
Board of Directors
Executive Move
Board of Directors
Promotion
Executive Move
Funding
KeifeRx News & Media
KeifeRx to Present at Sachs Neuroscience Forum and Biotech Showcase During J.P. Morgan Healthcare Conference Week
KeifeRx, announced that Chief Executive Officer Chris Hoyt will be speaking at two leading investor events during J.P. Morgan Healthcare Conference week. WASHINGTON, DC, UNITED STATES, January 5, 2026 /EINPresswire.com/ -- KeifeRx, a biopharmaceutical …KeifeRx Announces Expansion of Scientific Advisory Board
KeifeRx Strengthens Scientific Advisory Board with Leaders in Neurodegeneration to Support Drug Development and Strategic Partnering MCLEAN, VA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- KeifeRx Strengthens Scientific Advisory Board with …KeifeRx Announces the Appointments of Dan Feehan and Alison Finger to Board of Directors
WASHINGTON--(BUSINESS WIRE)--KeifeRx, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announces the appointments of Dan Feehan and Alison Finger to its Board of Directors. Mr. Feehan and Ms. Finger’s diverse expertise and experience enhance KeifeRx’s ability to develop its expanding pipeline of novel kinase inhibitors for the treatment of neurodegenerative, neuroinflammatory, aKeifeRx Appoints Garrett Vygantas, MD, MBA, to Board of Directors
WASHINGTON, Feb. 14, 2023 /PRNewswire/ -- KeifeRx, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announced today the appointment of Garrett Vygantas, MD, MBA, to serve...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KeifeRx
Sign Up For FreeTo access detailed company insights
Headquartered in Mclean, VA, KeifeRx is a biotechnology company with a focus on neurodegenerative diseases.... Read More
